Updated:
BioCatch
BioCatch is a global leader in digital fraud detection and financial crime prevention powered by behavioral biometric intelligence. Its BioCatch Connect...
BioCatch
BioCatch is a global leader in digital fraud detection and financial crime prevention powered by behavioral biometric intelligence. Its BioCatch Connect platform unites real-time telemetry, behavioral analysis, and predictive intelligence to detect and prevent account opening fraud, account takeover, social engineering scams, and mule accounts. The company analyzes thousands of user interactions and collects more than 3,000 anonymized data points to distinguish criminal from legitimate behavior for banks and financial institutions.
General information
Firm type
Asset Manager
Location
Country
Israel
City
Tel Aviv
Principals
Gadi Mazor
Chief Executive Officer
Itai Novick
Chief Science Officer
Greg Stockett
Chief Financial Officer
Amelia Ahlgren Lurie
Chief Strategy Officer
Mike Keating
Chief Revenue Officer
Ayelet Eliezer
Chief Product Officer
Eyran Blumberg
Chief Operating Officer
Oran Tamir
Chief R&D Officer
Sector focus
Frequently asked questions
Who runs investment decisions at BioCatch?
BioCatch is an operating company, not an investment firm. All strategic and financial decisions are managed by its internal leadership team, led by CEO Gadi Mazor. Greg Stockett, the Chief Financial Officer, oversees capital allocation and financial management. The firm has not publicly disclosed a formal investment committee or separate investment arm.
How does BioCatch source its behavioral data?
BioCatch captures behavioral telemetry directly from end-user interactions within its banking clients' digital applications. The system collects over 3,000 signals — including mouse dynamics, keystroke patterns, and navigation gestures — during live sessions. This data is processed via the firm's cloud platform, which applies behavioral sequencing and machine-learning models trained on its corpus of more than 16 billion analyzed sessions.
Which sectors does BioCatch serve, and which does it explicitly avoid?
The firm focuses almost exclusively on financial institutions — it states its technology protects digital banking customers. There is no public evidence of deployment in non-banking verticals such as healthcare, gaming, or government identity verification, though its behavioral sequencing models are technically sector-agnostic.
What is BioCatch's known posture on integrating with existing bank fraud stacks?
BioCatch positions its behavioral-intelligence signal as a complementary layer, not a replacement for a bank's existing fraud controls. The platform is designed to deliver a real-time risk score that banks can feed into their own decision engines, case-management systems, and step-up-authentication flows to add a behavioral-intent dimension to transaction risk analysis.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: